(AVGE) Avantis All Equity Markets - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0250722321

Equity, ETF, Diversified, Global

Dividends

Dividend Yield 1.69%
Yield on Cost 5y 3.07%
Yield CAGR 5y 83.55%
Payout Consistency 100.0%
Payout Ratio -
Risk via 5d forecast
Volatility 12.2%
Value at Risk 5%th 20.6%
Relative Tail Risk 2.57%
Reward TTM
Sharpe Ratio 0.68
Alpha 3.36
CAGR/Max DD 1.06
Character TTM
Hurst Exponent 0.435
Beta 0.835
Beta Downside 0.881
Drawdowns 3y
Max DD 17.13%
Mean DD 2.54%
Median DD 1.48%

Description: AVGE Avantis All Equity Markets October 23, 2025

Avantis All Equity Markets ETF (NYSE ARCA: AVGE) is a U.S.-registered fund that commits at least 80% of its net assets to equity exchange-traded funds. The manager allocates across multiple underlying ETFs to capture a globally diversified basket of large-cap stocks, tilting toward securities that are expected to deliver higher returns or superior risk-adjusted profiles than a traditional market-cap weighted index.

Key metrics (as of Q3 2024) include an expense ratio of 0.20%, total assets under management of roughly $1.2 billion, and a 12-month trailing return of 7.8%, modestly outperforming the MSCI ACWI (≈ 7.2%). The fund’s regional split is approximately 55% U.S., 25% Europe, 12% Asia-Pacific, and 8% Emerging Markets, with sector weightings tilted toward technology (≈ 22%) and consumer discretionary (≈ 15%). Recent macro drivers-such as the Fed’s incremental rate policy and resilient global consumer spending-support a continued bias toward growth-oriented large caps.

If you want a deeper, data-driven view of how AVGE’s factor tilts compare to peers, the ValueRay platform offers interactive analytics that can help you test the assumptions behind its expected-return profile.

What is the price of AVGE shares?

As of December 14, 2025, the stock is trading at USD 86.43 with a total of 35,512 shares traded.
Over the past week, the price has changed by +0.37%, over one month by +1.51%, over three months by +4.49% and over the past year by +16.23%.

Is AVGE a buy, sell or hold?

Avantis All Equity Markets has no consensus analysts rating.

What are the forecasts/targets for the AVGE price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 99.2 14.8%

AVGE Fundamental Data Overview December 12, 2025

Market Cap USD = 662.5m (662.5m USD * 1.0 USD.USD)
Beta = 1.06
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 662.5m USD (662.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 662.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 662.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.09% (E(662.5m)/V(662.5m) * Re(9.09%) + (debt-free company))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for AVGE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle